Perrigo Co PLC (PRGO)
32.79
-0.27
(-0.82%)
USD |
NYSE |
May 03, 16:00
32.79
0.00 (0.00%)
After-Hours: 20:00
Perrigo Revenue (Quarterly): 1.157B for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.157B |
| September 30, 2023 | 1.124B |
| June 30, 2023 | 1.193B |
| March 31, 2023 | 1.182B |
| December 31, 2022 | 1.155B |
| September 30, 2022 | 1.100B |
| June 30, 2022 | 1.122B |
| March 31, 2022 | 1.074B |
| December 31, 2021 | 1.105B |
| September 30, 2021 | 1.043B |
| June 30, 2021 | 981.10M |
| March 31, 2021 | 1.01B |
| December 31, 2020 | 1.053B |
| September 30, 2020 | 1.003B |
| June 30, 2020 | 948.80M |
| March 31, 2020 | 1.083B |
| December 31, 2019 | 355.30M |
| September 30, 2019 | 1.191B |
| June 30, 2019 | 1.149B |
| March 31, 2019 | 1.174B |
| December 31, 2018 | 1.195B |
| September 30, 2018 | 1.133B |
| June 30, 2018 | 1.186B |
| March 31, 2018 | 1.217B |
| December 31, 2017 | 1.283B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.231B |
| June 30, 2017 | 1.238B |
| March 31, 2017 | 1.194B |
| December 31, 2016 | 1.331B |
| September 30, 2016 | 1.262B |
| June 30, 2016 | 1.340B |
| March 31, 2016 | 1.383B |
| December 31, 2015 | 1.425B |
| September 30, 2015 | 1.345B |
| June 30, 2015 | 1.155B |
| March 31, 2015 | 1.049B |
| December 31, 2014 | 1.072B |
| September 30, 2014 | 951.50M |
| June 30, 2014 | 997.50M |
| March 31, 2014 | 1.004B |
| December 31, 2013 | 979.00M |
| September 30, 2013 | 933.40M |
| June 30, 2013 | 967.20M |
| March 31, 2013 | 919.80M |
| December 31, 2012 | 883.00M |
| September 30, 2012 | 769.80M |
| June 30, 2012 | 831.72M |
| March 31, 2012 | 778.02M |
| December 31, 2011 | 838.17M |
| September 30, 2011 | 725.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
355.30M
Minimum
Dec 2019
1.193B
Maximum
Jun 2023
1.054B
Average
1.100B
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Alkermes PLC | 350.37M |
| Endo International PLC | 497.73M |
| Jazz Pharmaceuticals PLC | 901.98M |
| Medtronic PLC | 8.089B |
| Iterum Therapeutics PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.30M |
| Total Expenses (Quarterly) | 1.066B |
| EPS Diluted (Quarterly) | -0.24 |
| Enterprise Value | 7.766B |
| Gross Profit Margin (Quarterly) | 36.93% |
| Profit Margin (Quarterly) | -2.79% |
| Earnings Yield | -0.30% |
| Operating Earnings Yield | 6.37% |
| Normalized Earnings Yield | 2.170 |